Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation

被引：4
|
作者：
Esmail, A. [1 ]
Xu, J. [1 ]
Umoru, G. [1 ]
Al-Rawi, H. [1 ]
Saharia, A. [1 ]
Abdelrahim, M. [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.04.259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-169
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [1] Gemcitabine plus Cisplatin versus non-gemcitabine and Cisplatin as neo-adjuvant for cholangiocarcinoma patients prior to liver transplantation
    Abdelrahim, M.
    Esmail, A.
    Xu, J.
    Saharia, A.
    McMillan, R.
    Kodali, S.
    Umoru, G.
    Ghobrial, R. M.
    [J]. TRANSPLANTATION, 2022, 106 (8S) : 158 - 158
  • [2] Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
    Abdelrahim, Maen
    Al-Rawi, Hadeel
    Esmail, Abdullah
    Xu, Jiaqiong
    Umoru, Godsfavour
    Ibnshamsah, Fahad
    Abudayyeh, Ala
    Victor, David
    Saharia, Ashish
    McMillan, Robert
    Al Najjar, Ebtesam
    Bugazia, Doaa
    Al-Rawi, Maryam
    Ghobrial, Rafik M.
    [J]. CURRENT ONCOLOGY, 2022, 29 (05) : 3585 - 3594
  • [3] Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma
    Abdelrahim, M.
    Esmail, A.
    Xu, J.
    Umoru, G.
    Al-Rawi, H.
    Saharia, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S309 - S310
  • [4] Gemcitabine plus cisplatin versus non-gemcitabine and cisplatin regimens as neoadjuvant treatment for cholangiocarcinoma patients prior to liver transplantation.
    Abdelrahim, Maen
    Esmail, Abdullah
    Xu, Jiaqiong
    Umoru, Godsfavour
    Saharia, Ashish
    McMillan, Robert
    Ghobrial, Rafik Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16202 - E16202
  • [5] Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
    Abdelrahim, Maen
    Esmail, Abdullah
    Xu, Jiaqiong
    Umoru, Godsfavour
    Al-Rawi, Hadeel
    Saharia, Ashish
    Abudayyeh, Ala
    Victor, David
    McMillan, Robert
    Kodali, Sudha
    Ghobrial, Rafik M.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)
    Dash, A.
    Pettus, J. A.
    Bochner, B. H.
    Dalbagni, G.
    Donat, S. M.
    Herr, H. W.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] FAVORABLE OUTCOME PREDICTORS OF NEO-ADJUVANT PROTOCOL LIVER TRANSPLANTATION FOR UNRESECTABLE CHOLANGIOCARCINOMA: MAYO CLINIC FLORIDA EXPERIENCE
    Panjala, Chakri
    Nguyen, Justin H.
    Nakhleh, Raouf E.
    Harnois, Denise M.
    [J]. HEPATOLOGY, 2009, 50 (04) : 1094A - 1095A
  • [8] The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review
    Cremen, Sinead
    Kelly, Michael E.
    Gallagher, Tom K.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation
    Minoux, Kate
    Lassailly, Guillaume
    Ningarhari, Massih
    Lubret, Henri
    El Amrani, Medhi
    Canva, Valerie
    Truant, Stephanie
    Mathurin, Philippe
    Louvet, Alexandre
    Lebuffe, Gilles
    Goria, Odile
    Nguyen-Khac, Eric
    Boleslawski, Emmanuel
    Dharancy, Sebastien
    [J]. TRANSPLANT INTERNATIONAL, 2022, 35
  • [10] Neo-adjuvant treatment in patients with pancreatic cancer with nab-paclitaxel and gemcitabine
    Pomillo, A.
    Santoro, M.
    Iuliano, E.
    Luci, M.
    Perricelli, A.
    Iuliano, F.
    Mazzulla, M. F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345